Buzz Pocket

Monday, August 16, 2021

The COVID-19 Fallout: Enzymes Market in 2020 - What Does the Year Ahead Hold?

The outbreak of COVID-19 has a marginal impact on the enzyme market. The sustainability of this market is majorly attributed to the extensively rising demand in bio-detergent, biofuels, pulp and paper manufacturing processes, rubber manufacturing, and molecular biology. Due to the COVID-19 pandemic, the majority of the ventures which are operating in the manufacturing of enzymes are currently working on the production sanitizers to fight against COVID-19. For example, in April 2020, BASF, the largest enzyme manufactures company, has started production of hand sanitizer to support the fight against COVID-19 in New York and New Jersey. This may cause a considerable decline in the growth of the global enzyme market, in the global market. However, as per the publication of Amway, they will increase the production and supply of immunity-building products in view of the COVID-19 pandemic crisis. These factors may drive the demand for enzymes in the global market, during the forecast period. The company such as AB enzymes has taken strategic decisions to follow the World Health Organization (WHO) and local government advice regarding the global network of sites.

AB enzymes safeguarding the health employees along with continuing to supply solutions for customers’ applications. By utilizing such strategies, the enzyme ventures across the world are preparing for the post-pandemic impact. During this unprecedented situation, we are helping our clients in understanding the impact of COVID19 on the Global Enzyme.

As per a new publication of Research Dive, the global enzyme is set to generate revenue of $17,875.7 million by 2026, at a CAGR of 9.4% during the forecast period.

The segmentation of the market has been done on the basis of source, product, application, and region. The report provides in-depth insights on drivers, opportunities, restraints, vital segments, and leading industry players of the market. As per our analyst estimates, enzymes have functional versatility along with it has wide applications in multiple fields is key factors propelling the enzyme market growth. Contrary to this, safety and handling issues regarding enzymes are projected to hamper the growth of the global enzyme market, during the period of forecast.

Micro-organisms for the global enzyme market will have the fastest growth During 2020-27

On the basis of source, the global market for an enzyme is classified into micro-organisms, Plants, Animals. The micro-organisms market is valued at $7,565.0 million revenue in 2018 and is expected to grow at 9.6% CAGR by the end of 2026. The growth of the micro-organisms segment is prominently driven by the significant capability of micro-organisms to produce enzymes with a wider range of applications.

Lipase will register substantial market growth during the period of forecast

Based on the product the enzyme is broadly categorized into polymerases & nucleases, proteases, carbohydrase, lipases, and others, The market size for lipases segment accounted for $2,752.9 million in 2026 and is expected to boost at a CAGR of 9.8% during the forecast period; this is mainly because of its significant role in the water purification as well as the dairy industry

Specialty enzymes will generate significant market growth

On the basis of application, the global market is fragmented into industrial enzymes and specialty enzymes. The market size for specialty enzyme accounted for $9,295.4 million in 2026 and is projected to grow at a healthy CAGR of 10.5% during the period of forecast; this majorly because specialty enzymes have significant usage in chronic disease therapies such as lysosomal diseases and CVD’s (cardiovascular diseases).

Geographical Analysis and Major Market Players

On the basis of region, the global for enzyme market is classified into North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific Enzyme market valued at $4,647.7 million in 2026 and is anticipated to rise at 9.9% CAGR during the period of forecast. This is mainly because of the rapid expansion of food & beverages, detergent, and pharmaceutical industries significantly in South Korea, Japan, and Singapore.

The major players of the global enzyme market consist of BASF, Royal DSM, Enmex, Danisco A/S, Advanced Enzymes, Chr. Hansen, Lumis Biotech, Hayashibara, Aumgene Biosciences, and Codexis.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Toll Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Corona Impact: Is Coagulation Testing Market will Propel with its Advanced Approaches in 2020

The COVID-19 outbreak had a huge impact on the overall market for coagulation testing. The Instruments products type will be the most lucrative. The Asia-Pacific region will have good opportunities. The key players are developing strategies to achieve a competitive advantage in the industry.

As per the report by Research Dive, the global coagulation testing market is expected to reach up to $3,814.3 million by 2026, and to grow to 7.1% in the forecasted period between 2019 and 2026. COVID-19 outbreak has had a major impact on the coagulation testing market, and it is anticipated that there will be significant market growth. New research indicated that the main cause of deaths in COVID-19 patients with severe disease is coagulation dysfunctions. This coagulation dysfunction occurs primarily because of acute respiratory failure and coagulation of the blood (thrombosis).

Furthermore, in the COVID-19 outbreak period, many governments are taking various initiatives to support companies. The People’s Liberation Army Professional Committee of Critical Care Medicine and Chinese society, have come together to establish an expert consensus on coagulation dysfunction treatment and diagnosis related to a severe COVID-19 virus. In this time of crisis, these factors significantly drive market growth.

Highlights of the Report:

The global coagulation testing market has witnessed remarkable growth in the previous years. The sudden outbreak of coronavirus has impacted the market, bringing even more chances of growth. As per the report, the global coagulation testing market industry is expected to register a revenue of $3,814.3 million by 2026, at a growth rate of 7.1% during the forthcoming years. In the current situation, the market has garnered $2,555.1 million owing to the importance of coagulation testing therapies during the complete shutdown.

Factors Impacting the Market Growth amidst Covid-19 Pandemic

The benefits of coagulation testing, as well as the common use of coagulation testing treatments for hematology and thrombosis in hospitals and clinical laboratories, will drive the markets in the projected period. Conversely, the prohibitive cost of testing coagulation limits the market growth. Furthermore, the lack of skilled testing for coagulation and the use of analyzers could impede the industry’s growth.

Current Market Transformation Due to Covid-19:

– The current state of the market

The COVID-19 pandemic impacted the overall test-coagulation market positively. The analysis of a series of coagulation tests (PET) is carried out by researchers in the susceptibility tests of COVID-19 patients, such as platelet, fibrinogen, and dimer. There have been reports that patients with higher rates of D-dimers are more likely to face death. Many other government officials have taken a variety of steps to promote businesses during the pandemic. The Chinese government, for example, recently unveiled a new series of technical innovations to support new vertical business growth structures such as cloud, internet, industrial internet, and SOE technology. The government has decided to improve technology in the areas of telemedicine, life sciences, pharmaceutics, and pharmacy. However, the high costs associated with diagnosis and study should constrain market growth. Furthermore, the lack of qualified coagulation tests and the use of analyzers could also hamper industry growth.

Post-pandemic Market Insights:

As per the report, there are plans to maintain sustainable growth after the pandemic in the global coagulation test market. It is expected that in the coming few years, some of the leading market players will bring innovative progress and rewarding opportunities to the market. Some of these key players include Helena Laboratory Corporation, Thermo Fisher Scientific Inc., Micropoint Biosciences, F. Hoffmann La Roche Ltd, Medtronic, NIHON KOHDEN CORPORATION, Sysmex Corporation, Abbott and Danaher, among others.

Contact Us:

COVID-19 Impact Review: What Challenges Cancer Stem Cells Market May See In Next 5 Years?

The COVID-19 tragedy is expected to create a positive impact on the global cancer stem cells market. The bladder cancer segment is projected to grab major share of the market. The targeted cancerous stem cells segment is projected to observe significant growth. The Asia Pacific region is expected to lead the global market throughout the forecast period. The major players of the market are implementing several strategies to withstand their business amidst this catastrophic situation.

At this moment in time, the whole world is in havoc owing to the abrupt outburst of COVID-19 pandemic. However, this pandemic situation has created a positive impact on the global cancer stem cells market. A latest report published by Research Dive reveals that the global cancer stem cells market is anticipated to gather $1,898.3 billion by 2026, rising at a growth rate of 11.8% from 2019 to 2026. The report segments the global market into application, cancer forms, and region. The report provides comprehensive analysis of the impact of COVID-19 on the key drivers, opportunities, limitations, key segments, and top players of the global market.

Factors Impelling the Market Growth amidst COVID-19 Crisis

Regardless of the outbreak of COVID-19 pandemic, government bodies all over the world are hugely investing on research & development activities to enhance the use of cancer stem cells in the cancer treatments. Additionally, the development of stem cells for stem line banking and developing induced Pluri-Potent Stem Cell (PSC) lines is massively boosting the growth of the cancer stem cells market.

Bladder Cancer Segment to Seize Largest Share of the Market

Based on cancer forms, the report categorizes the global cancer stem cells market into brain, breast, bladder, liver, blood, pancreatic, lung, colorectal, and other. The bladder segment is dominating the market ever since 2018 and is predicted to gather $303.9 million by 2026. This segment is expected to grow majorly owing to the rising number of deaths due to bladder cancer, all over the world. According to the U.S. government, bladder cancer is the fifth most occurring cancer among all other types of cancer, and therefore it is optimistically influencing the global market growth throughout the projected period.

Targeted Cancerous Stem Cells Segment to Experience Considerable Growth

Based on application, the report divides the global market into targeted cancerous stem cells and stem cells-cancer therapy. Among these, the targeted cancerous stem cells segment is anticipated to observe significant growth at a CAGR of 13.0% throughout the projected period. As targeted cancerous stem cells have the ability to attract normal cells, they can be used positively to target cancer cells; this factor is greatly boosting the growth of this segment.

Regional Breakdown of the Market

Regionally, the report studies the market across North America, Asia-Pacific, Europe, and LAMEA. Among these, the Asia-Pacific region is anticipated to lead the global market by garnering $405.17 million by 2026. This is mostly due to the presence of considerable number of scientists in this region that are involved in R&D activities related to stem cell therapy.

Key Market Players

The prominent players in the global cancer stem cells market are Merck KGaA, AbbVie Inc., Irvine Scientific, Stem Cell Technologies Inc., MiltenyiBiotec, Thermo Fisher Scientific Inc., OncoMed Pharmaceuticals, Sino Biological Inc., BioTime Inc., and others. These market players are implementing various tactics to survive during this pandemic situation.

Contact Us:

Is Plasma Therapy Market Trapped Between Growth Expectations And Uncertainty?

The Covid-19 pandemic is anticipated to affect the worldwide computer aided drug discovery market positively. The respiratory disease therapeutic segment will generate a considerable amount of the global market share. The pharmaceutical end-user segment is anticipated to reach newer heights. The structure-based drug design segment is foreseen to overwhelm the global market share. The Asia-Pacific region will generate huge investment opportunities in the conjecturetime frame. The key players of the market are concentrating on various strategies to sustain in these trying times.

The sudden eruption of COVID-19 pandemic has imposed positive impact on the computer aided drug discovery market. Widespread coronavirus has influenced numerous medical organizations for the advancement of vaccines to treat infected persons around the world. According to a recent publication by Pharmaceutical Science and Computational Chemical Genomics Screening Centre, distinguishing proof of antibody or medication treatment for COVID-19 is studied using the computational drug repurposing method. This study has contributed to the development of vaccine for COVID-19 infection. Also besides, it stated that computer-aided drug design is an efficient procedure to contemplate the 3-dimensional structure of virus protein. Likewise, chloroquine phosphate is utilized for the treatment of COVID-19 infected persons. But according to publication made by Dr. Talluri Sekhar, this chloroquine is used to treat a few patients. Thus several studies are carried out to study the genomic structure and develop chloroquine with the help of computer-aided technology to utilize it on severely ill patients.

In addition, a team of Chinese scientists stated that the high-resolution crystal structure of the COVID-19 virus has been studied and developed an antiviral drug that can combat the virus. This protease structure was studied using virtual drug screening and structure-assist drug design. Thus these factors are driving the demand of the global computer aided drug discovery market in the forecast period of time. During this unique situation, our analysts are helping our clients in understanding the impact of COVID19 on the Computer aided drug discovery Market by providing them with an in-depth analysis.

As per a recent report published by Research Dive, the global computer aided drug discovery market is set to generate a revenue of $5,427.2 billion by 2026, at a CAGR of 16.9% during the forecast period from 2019 to 2026.

The global CADD market has been fragmented on the basis of type, therapeutic area, end-user and region. The computer aided drug discovery report provides in-depth insights on drivers, vital segments, opportunities, restraints, and key players of the market. As per our analysts, increased utilization of CADD method for various phase of drug development is expected to drive the global computer aided drug discovery market. However,it is difficult to copy and simulate the complete biological system on a computer system and flexibility are the factors restraining the market growth.

Structure-Based Drug Design Type to Have Dominant Share

Based on type, the global computer aided drug discovery market is classified into structure-based drug design (SBDD), ligand-based drug design (LBDD), and sequence-based approaches. The structure-based drug design segment represented $489.8 billion income in 2018 and is anticipated to develop at 17.3% CAGR by the end of 2026. This design is the developing iterative and ground-breaking approach for auxiliary assessment of drug discovery process and it is cost-effective method as compared to other design type.

Respiratory Disease Therapeutic Area to be Most Lucrative

In view oftherapeutic area, the global market for the computer aided drug discovery is segmented into oncology, neurology, cardiovascular disease, respiratory disease, diabetes and others. The market size for the respiratory disease accounted for $243.4 billion in 2018 and is estimated to grow with the highest CAGR of 17.3% CAGR by 2026. This development is attributed to the fast ascent in the respiratory issues due to growing prevalence for smoking and COVID-19 patients.

Pharmaceutical Companies to be Most Lucrative

On the basis of end-user, the computer aided drug discovery market is divided into pharmaceutical companies, biotechnology companies, research institutes and others. Pharmaceutical company segment is anticipated to dominate the global computer aided drug discovery market. Pharmaceutical company vertical accounted for $452.9 billion in 2018 and is projected to grow with a CAGR of 17.2% during the projected time frame. The growth is attributed due to the increasing demand for development of appropriate vaccine to treat COVID-19 patients around the world.

Geographical Analysis and Major Market Players

Based on the region, the global computer aided drug discovery market is segmented into North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific computer aided drug discovery market accounted for $411.3 billion in 2018 and is anticipated to rise at 17.6% CAGR throughout the forecast period. The growth is majorly attributed to the presence of major key-players in this region and their increasing investments for research & development activities to widen the utilization of CADD.

The major players of the global computer aided drug discovery market include BOC Sciences, BioDuro, Schrödinger, Aris Pharmaceuticals, Aragen Bioscience, Albany Molecular Research Inc. (AMRI), Charles River, AstraZeneca, Evotec A.G., and Bayers AG.

Contact Us:

How Computer Aided Drug Discovery Market Will Grow In Coming Future Despite COVID-19 Chaos?

The COVID-19 pandemic is anticipated to have a positive impact on the global plasma therapy market. The PRP segment is estimated to play a dominant role in the market during the forecast period. By source, the autologous segment is projected to witness a considerable growth by 2026. In addition, the Asia Pacific region is expected to create massive growth opportunities in the global market. Majority of the prominent players of the industry are adopting several strategies to strengthen their market position in these unprecedented times.

The global plasma therapy market is projected to garner $432.8 million by 2026, rising at a healthy CAGR of 16.3% from 2019 to 2026, reveals a new Research Dive published report. The report segments the global market into source, type, end-use, application, and region. The study offers comprehensive analysis of drivers, opportunities, restraints, vital segments, and top market players. As per the report, cumulative demand for plasma treatment for treating orthopedic conditions & neurological disorders and growing awareness amongst people regarding dental health & personalized healthcare systems are significant factors boosting the growth of the global plasma therapy market. Conversely, high expenses involved in plasma therapy is a prime factor predicted to restraint the market growth during the forecast period.

Growing Positively Despite COVID-19 Chaos

This sudden outburst of coronavirus pandemic has imposed an optimistic impact on the global plasma therapy market. This market is anticipated to observe significant growth during this pandemic period. Presently, scientists from various parts of the world are concentrating on numerous possibilities to invent an effective treatment or vaccine that can combat this life-threatening disease. Researchers are majorly considering the plasma therapy technique as a possible treatment for this disease. This factor is considerably boosting the demand for plasma therapy for the treatment of COVID-19 disease, thus boosting the market growth during the pandemic period.

PRP Segment to Play a Dominant Role in the Industry

By types, the global market for plasma therapy is divided into pure platelet-rich plasma (PRP), leukocyte-rich fibrin, leucocyte-rich PRP, and pure platelet-rich fibrin. Of these, the pure PRP segment accounted for $50.1 million in 2018 and is expected to rise at a healthy growth rate of 16.7% during the period of forecast. This growth is mainly attributed to the growing usage of pure PRP in the treatment of neurosurgery, orthopedics/spinal surgery, cosmetic surgery, and others due to its cost effectiveness than its other counterparts.

Autologous Source Segment to Lead the Market

Based on source, the global industry is classified into autologous and allogeneic. Among these, the autologous source segment is anticipated to reach up to $298.6 million by 2026. This segment is further expected to dominate the market throughout the forecast because autologous biologics plays a vital role in tissue repair and generation treatments and also helps in enhancing the healing power of recalcitrant and chronic wounds.

Regional Breakdown of the Market

Regionally, the report evaluates the global market across North America, Asia Pacific, Europe, and LAMEA. The North American region grabbed the majority of market share in 2018 and is expected to surpass $155.8 million revenue by 2026. This is primarily owing to the developments in advanced protein fractioning procedures and surging demand for plasma therapy techniques from hospitals & clinics in this region. Besides, the Asia-Pacific market for plasma therapy is projected to experience an impressive growth and generate rewarding growth opportunities during the estimated timeframe.

Major Market Players

The leading players functioning in the global plasma therapy market include Kedrion S.p.A, Grifols, S.A., CSL Limited, Cambryn Biologics, LLC, Bio Products Laboratory Ltd, Octapharma AG, BioLife PLASMA SERVICES, Biotest AG, China Biologic Products Holdings, Inc., and others. These players are involved into implementing several business ploys such as acquisitions, mergers, and collaborations & partnerships to obtain a major market share in the global industry.

Contact Us:

COVID-19 Outbreak: How Chromatography System Market Will Shape Having Biggies with Strong Fundamentals?

The COVID-19 crisis is expected to impact global chromatography systems market in an affirmative way. Liquid chromatography type will harvest highest revenue of the global market shares. Pharmaceutical and biotechnology end-user segment will produce peak revenue in the global market share. The Asia-Pacific region will take over the global market share in the forecast period. The key players are concentrating on various strategies to sustain in these tough times.

The world is facing an unpredicted change and many of the industries are experiencing thought aggravating situation due to the COVID-19 pandemic. The COVID-19 outbreak has positively impacted the chromatography system market. Upsurge in the utilization of chromatography systems for separation of complex mixtures and identification of cancer cells in the human body is a major growth driver. Moreover, it is also utilized for testing drinking water, plasma fractionation and insulin purification. During this coronavirus crisis situation, we are helping our clients in understanding the impact of COVID-19 on the chromatography system market.

According to a new report by Research Dive, the global chromatography system market is estimated to generate revenue of $16,304.0 million by 2026, at a CAGR of 6.9% in the forecast time from 2019 to 2026. The global chromatography systems market is bifurcated on the basis of type, end use and region. The report provides detailed information about drivers, opportunities, restraints, segmental analysis and competitive players of the market. As per our analysts, growing demand for chromatography techniques in various end-use industries such as hospitals, agriculture, food industry, and pharmaceuticals is significantly increasing the demand of the chromatography systems. However, requirement of highly skilled persons to operate the system, increased cost of the equipments and complexity involved in the chromatography systems are expected to hamper the chromatography system market growth.

Liquid Chromatography Segment has Dominant Market Share

In light to type, the overall market is segmented into liquid chromatography, gas chromatography, and others. Among these, liquid chromatography technique subjugated the market in the year 2018 and is expected to register for $6,567.9million in 2026. HPLC is widely used liquid chromatography techniques owing to its beneficial properties such as use of slid adsorbent material, rapid separation rate, and use of pump rather than gravity for separation of solvents. In addition, it is also utilized in the analysis of various applications such as polymers, clinical fields, plastics, and environmental monitoring will accelerate the growth of the market in the projected time.

Pharmaceutical and Biotechnology End Use Will Grow at a Significant Rate throughout the Forecast Years

On the basis of end use, the chromatography system market is classified into hospital & research, pharmaceutical & biotechnology, and agriculture & food industry. The market for pharmaceutical & biotechnology will witness to mount at a faster rate of 7.3% CAGR and is predicted to register for $5,651.4 million till the end of 2026. Chromatography technique has gained importance in the pharmaceutical industry owing to the ability to identify and quantify drugs that may be in both forms i.e., formulation or active pharmaceutical ingredient. In addition, chromatography technique in pharmaceutical and biotechnology end-user is utilized for content uniformity, drug development, and validation of drugs; these factors will fuel the market size in the forecast time. Hospital & Research Industry end use segment accounted for an evident market size and is projected to experience considerable growth during the forecast time.

Regional Outlook and Major Market Players

Asia-Pacific market has dominated the global market share, and is estimated to reach up to $3,283.9 million till 2026. Asia-Pacific region has gained increased importance of chromatography techniques due to widen utilization of this techniques for various purposes such as evaluation of heavy metal pollution materials, chemical composition analysis of Toona Sinensis bark by using gas chromatography, and filtration of municipal waste water. For example, Waste Water Treatment Plant based in Tianjin successfully used chromatography technique for separation of waste from municipal water. Asia-Pacific RO water treatment system component market will experience a noteworthy growth and projected to generate revenue of $3,283.9 million by the end of 2026, at a CAGR of 7.5%.

The most prominent players in the global chromatography system market include Agilent Technologies, Perkin Elmer, APIX, Thermo Fisher Scientific Inc., Xylem (OI Analytical), CDS Analytical, Shimadzu Corporation, Waters Corporation, Jasco Inc, Bio-Rad Laboratories and others.

Contact Us:

Friday, August 13, 2021

What Neuromodulation Devices Market Is Aiming Next: Leveraged Returns Or Disaster?

The neuromodulation devices market is predicted to grow significantly in the forecast period despite of the pandemic COVID-19 situation. The growth for the market is predicted due to rise in the prevalence of the chronic diseases across the globe. Mostly, people use to be dependent on various dugs and medication to cure themselves where the patient curing success ratio was very less as compared to neurological treatment. The hospitals are struggling as the disease is spreading more than the production of masks, sanitizers, ventilators and tests. The neuromodulation devices are predicted to treat the corona patients and the process is under trial. SARS-Cov2 is likely to be responsible for acute respiratory failure and are treated with the help of neuromodulation devices.

At the pandemic situation many firms are under process for getting a device to cure corona virus with the help of a type in neuromodulation device. Vagus nerve stimulation is a type of neuromodulation device which can be treated through nerves which connects bidirectional to various organs, which includes even lungs. So, vagus nerve stimulation are under trial and are mostly used to lessen pain that occurs because of corona virus and the patient is predicted to recover within 15 days.

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

As per a new report published by Research Dive, the global neuromodulation devices market is set to generate a revenue of $ 26,418.6 by 2026, at a CAGR of 19.7% during the forecast period from 2019 to 2026.

The segmentation of the market has been done on the basis of type, application, end user and region. The report provides in-depth insights on drivers, vital segments, opportunities, restraints, and key players of the market. As per our analysts, increasing prevalence’s of chronic diseases such as depression, epilepsy, spinal problem and other diseases among the population is predicted to boost the neuromodulation devices market. Moreover, the cost involved in treating neurological diseases is very high, which is predicted to hinder the neuromodulation devices market in the forecast period.

Cheddar type segment is predicted to be most lucrative

Depending on type, the neuromodulation devices market is segmented into internal neuromodulator and external neuromodulator. Internal Neuromodulation segment accounted for $3,647.5 million in 2018 and is predicted to grow with a CAGR of 19.4% in the forecast period. Internal neuromodulation is the most cost effective and is the most effective way of treating chronic pain, tremor, and several diseases, which is predicted to boost the internal neuromodulation segment in the forecast period.

Supermarket distribution channel is predicted grow immensely in the forecast period

Depending on application, the neuromodulation devices market is segmented into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, repetitive transcranial magnetic stimulation, respiratory electrical stimulation and others. Spinal cord stimulation segment was accounted for $1,193.7 million in 2018 and is predicted to grow with a CAGR of 18.9% in the forecast period. The neuromodulation devices are mostly used for the treatment of the spinal cord treatment across the globe is predicted to boost the spinal cord stimulation segment in the forecast period.

Hospital end use segment is predicted to have the highest share in the forecast period

Depending on end use, the neuromodulation devices market is segmented into clinical, hospital and home health care. Hospital segment accounted for $3,382.2 million in 2018 and is predicted to grow with a CAGR of 19.3% in the forecast period.

Geographical Analysis and Major Market Players

On the basis of region, the global disaster recovery as a service market is segmented into North America, Europe, Asia Pacific, and LAMEA. Asia-Pacific market is predicted to grow with a CAGR of 19.7% in the forecast period by generating a revenue of $26,418.6 million by 2026.Increasing cases of neurological disorders, increasing investment in private & public hospitals & clinics with government initiatives is predicted to boost the overall market in the forecast period.

The major key players in the neuromodulation devices market are Boston Scientific Corporation, Neuronetics, Inc., Beijing PINS Medical Co., Ltd., Neuropace Inc. Bioness Inc., Nevro Corporation, LivaNova Plc, Abbott Laboratories and Medtronic Plc among others.

Contact Us:

Know the Rapid Growth Factors of Intensive Care Beds Market| Stay Up-To-Date With Emerging Trends Ahead

The emergence of COVID-19 all over the world has impacted the intensive care beds market. The increasing number of people admitting in hospitals due to ongoing corona virus crisis is predicted to be the major factor for the global market growth in 2020. Furthermore, technological advancements owing to increasing healthcare expenditure and growing R&D activities are estimated to boost the market growth after COVID-19 pandemic.

The global intensive care beds industry is predicted to witness an increase in growth rate due to the COVID-19 outbreak. According to Research Dive published report, the global intensive care beds market was likely to rise at a CAGR of 3.9% by 2027 prior to COVID-19 crisis. Now, due to the COVID-19 pandemic, the global market is expected to rise at a CAGR of 4.2% in the forecast period. This is mainly due to the increasing healthcare expenditure to enhance hospital facilities and the rise in number of hospitals & clinics all over the world. Comprehensive analysis on drivers, challenges, restraints, lucrative opportunities, and strategies implemented by market players and governments across the globe are further offered in the report.

Market Scenario During Pandemic in 2020

The projected pre COVID-19 market size for intensive care beds industry was $1,635.2 million in 2020 and is expected to witness a robust growth and reach up to $1,652.1 million due to COVID-19 pandemic. With the increasing COVID-19 cases, the demand for intensive care beds is increasing. Thus, the growing adoption of intensive care beds during the COVID-19 pandemic is predicted to be the major factor for the increase in market size in 2020. Besides, the major market players are increasingly focusing on improving production capacity and product efficiency in the pandemic, which is helping the global intensive care beds market to witness a progressive growth. For instance, in March 2020, a leading company in medical technology, Hillrom increased the manufacturing of critical care products such as hospital beds, vitals monitoring devices & accessories, and ventilators to support COVID-19 crisis.

Post-Pandemic Market Landscape till 2027

As per the report, the global intensive care beds market is expected to sustain a progressive growth even after the COVID-19 pandemic due to the increasing R&D activities and swift growth in technological advancements owing to growing healthcare expenditure. For instance, in April 2019, LINET demonstrated multi-care beds and the clinical advantages of lateralization for intensive care units (ICU) by making use of modern imaging technologies during a conference in Singapore. The leading players operating in the global market include Invacare Corporation, Hillrom, LINET, Merivaara Corp., Span America, Stryker, Medline Industries, Inc., Getinge AB, Malvestio Spa, and Stiegelmeyer GmbH & Co. KG. The report summarizes various aspects of all the prominent players functioning in the market such as financial performance, recent strategic moves & developments, product portfolio, and SWOT analysis.

Contact Us:

What Are the Manufacturers Evolving In the Growth of the Left Atrial Appendage Closure Devices Market?

The abrupt rise of COVID-19 pandemic has made a positive impact on the growth of the global left atrial appendage closure devices market in 2020. The increasing elderly population and rising cases of atrial fibrillation (AF) are fueling the demand for left atrial appendage closure devices during the COVID-19 crisis. Increasing product developments and technological advances by top market players are projected to unlock rewarding opportunities for the growth of the global market throughout the pandemic period.

The latest research report on the global left atrial appendage closure devices market by Research Dive divulges the impact of the COVID-19 pandemic on the current and forthcoming growth of the market. This report is a comprehensive research articulated by experts by studying top driving factors, regional market situations, latest trends and initiatives, and size & scope of the market in the course of the pandemic period.

Highlights of the Report

The sudden outburst of the COVID-19 pandemic has imposed a positive impact on the global left atrial appendage closure devices market. As per the report, the global left atrial appendage closure devices market had gathered a revenue of $466.6 million in 2019 and is expected to surpass $2,637.1 million by 2027, increasing at a CAGR of 24.0% from 2020 to 2027. The size of the market in the present situation has reached $585.2 million due to a rise in the cases of atrial fibrillation (AF) all over the world.

Factors Impacting the Market Growth during COVID-19 Pandemic

The global left atrial appendage closure devices market is anticipated to observe noteworthy growth owing to the global increase in the cases of atrial fibrillation and growth in the geriatric population. Additionally, growing number of patients suffering from heart and stroke disorders, who are highly vulnerable to atrial fibrillation, are expected to fuel the demand for left atrial appendage closure devices; thus leading to an increased growth of the market.

Current Face of the Market Due to COVID-19

In the course of the pandemic period, some of the foremost players in the left atrial appendage closure devices sector are implementing numerous strategies such as partnerships, collaborations, and novel product developments to grab a major position in the market. For example, in July 2020, the U.S. FDA (Food and Drug Administration) has given approval for the advanced Watchman FLX Left Atrial Appendage Closure device developed by Boston Scientific Corporation. This device is developed to minimize the possibility of stroke in NVAF (non-valvular atrial fibrillation) patients, who need a substitute for oral anticoagulation treatment by permanently sealing the left atrial appendage, the part of the heart in which stroke-causing blood clots are formed in NVAF patients.

Future Scope of the Market:

As per the report, the global left atrial appendage closure devices market is expected to undergo continuous growth post-coronavirus pandemic. New players and some of the major players including Cardia, Inc., Boston Scientific Corporation, Aegis Medical Group., AtriCure, Inc., SentreHEART, Inc., Abbott., Occlutech, Lifetech Scientific, Biosense Webster, Inc., Johnson & Johnson Services, Inc., and others are anticipated to shape the future of the global left atrial appendage closure devices industry in the next few years. The report summarizes various aspects of the prominent players functioning in the market such as financial performance, recent strategic moves & developments, product portfolio, and SWOT analysis.

Contact Us:

Driving Innovation: Home Infusion Therapy Market Is Projected to Grow at a Substantial Rate by 2027

The abrupt occurrence of COVID-19 pandemic has made a positive impact on the growth of the global home infusion therapy market in 2020. The growing geriatric population and rising cases of severe disorders are boosting the adoption of home infusion therapy during the COVID-19 crisis. Growing product launches and technological developments by leading companies is estimated to bring in rewarding opportunities for the growth of the global market during the pandemic period.

The newest research report on the global home infusion therapy market by Research Dive reveals the impact of the COVID-19 pandemic on the present and forthcoming growth of the market. This report is a meticulous research formulated by experts by reviewing regional market conditions, major driving factors, recent trends and developments, and size & scope of the market during the crisis period.

Highlights of the Report

The sudden outbreak of the COVID-19 pandemic has imposed a positive impact on the global home infusion therapy market. According to the report, the global home infusion therapy market had garnered a revenue of $20.2 billion in 2019 and is expected to exceed $49.5 billion by 2027, rising at a CAGR of 11.7% during the crisis period. The size of the market in the current scenario has reached $22.9 billion due to the increased adoption of home infusion therapy by patients during the COVID-19 turmoil.

Factors Impacting the Market Growth during COVID-19 Pandemic

The global home infusion therapy market is expected to witness significant growth due to the global rise in the cases of acute diseases and growth in the geriatric population that needs long-term medical treatments. Furthermore, growing preference for home-based treatment by sick people, which have low immunity, to avoid getting affected by the COVID-19 infection is boosting the demand for home infusion therapy and leading to an augmented growth of the market.

Current Market Scenario Due to COVID-19:

In the course of the pandemic period, some of the leading players in the home infusion therapy market are undertaking various strategies such as collaborations, partnerships, and new product development to withstand their market position. For example, in July 2020, Biocon biologics, an innovation led fully integrated biopharmaceutical firm, and Voluntis, a healthcare software company specialized in Patient Relationship Management (PRM), entered into a partnership to develop and offer advanced digital therapeutics based on biologics therapy for supporting diabetes patients.

On the other hand, government bodies in various COVID-19 affected areas are offering support to the home infusion therapy market players to sustain their business amidst the COVID-19 disaster. For example, in October 2019, the Medicare & Medicaid Services Centers have passed a law proclaiming that all home infusion therapy overheads will get covered under the Bipartisan Budget Act of 2018.

Future Scope of the Market:

As per the report, the global home infusion therapy market is expected to experience incessant growth post-coronavirus pandemic. New players and some of the major players including Fresenius Kabi, Baxter International, Inc., Smiths Medical., JMS Co., Ltd., ICU Medical Inc., Terumo Corporation, Eli Lilly and Company, Becton, Dickinson and Company (BD), B Braun Melsungen AG, Cosmed, and others are expected to mold the future of the global home infusion therapy market in the upcoming years.

Contact Us:

Industry Dynamics: Protective Face Masks Market 2021 to Witness Excellent Long-Term Growth Outlook

The emergence of COVID-19 across the globe has impacted the protective face masks market in a positive way. This is primarily owing to the rising cases of coronavirus coupled with the increasing need for face masks to prevent the transmission of infection. Moreover, the increasing demand for masks from healthcare institutions and the rising concern for safety are expected to be the major factors to fuel the market growth after COVID-19 pandemic.

The global protective face masks industry is likely to witness an increase in growth rate due to the outbreak of COVID-19. As per a new Research Dive published report, the global protective face masks market accounted for $1,073.1 million in 2019 and is projected to surpass $2,467.5 million by 2027. Comprehensive analysis on drivers, challenges, restraints, lucrative opportunities, and strategies implemented by market players and governments across the globe to sustain in the COVID-19 crisis are further offered in the report.

Pre Market Forecast and the Current Market Scenario

The global protective face masks industry was likely to rise at a CAGR of 10.2% by 2027 prior to COVID-19 crisis. While due to the COVID-19 pandemic, now the market is predicted to rise at a CAGR of 10.8% in the forecast period. This is mainly due to the increasing need for protective face masks due to the increasing cases of COVID-19.

The projected pre COVID-19 market size for protective face masks market was $1,176.5 million in 2020 and is expected to witness an impressive growth and reach up to $1,205.6 million due to COVID-19 pandemic. A number of companies are highly focusing on increasing the production of face masks owing to its high demand in the pandemic crisis. For instance, Arizona PPE Company has started mask production at Mesa facility.

Prominent Players of the Industry

The major players functioning in the global protective face masks market are 3M, Reckitt Benckiser Group plc, Polison Corporation, Moldex-Metric, Inc., JSP Ltd., Intech Safety Private Limited, Alpha Solway Ltd, Mine Safety Appliances (MSA) Company, Ansell Limited, and Delta Plus Group. The report summarizes various aspects of all these key players including product portfolio, financial performance, SWOT analysis, and recent strategic moves & developments.

Post-Pandemic Market Analysis

As per the report, the global protective face masks market is predicted to sustain its progressive growth even after the pandemic. The rising concern of people related to health & safety and the rising demand for face masks from healthcare institutions are expected to be the significant factors projected to boost the global market growth during the forecast period. In addition, the focus of most companies on developing innovative protective masks is predicted to create enormous growth opportunities in the global market after COVID-19 pandemic.

Contact Us: